VC  New Science Ventures

     Office Locations:

299 Park Avenue, 41st Floor
New York, NY 10171
Phone: 212-688-5100
Fax: 212-308-9196



  • Early
  • Expansion
  • Growth



  • Information Technology
  • Manufacturing & Industrial



    New Science Ventures, LLC (NSV) is a New York-based venture capital firm which invests in companies using novel scientific approaches in the Life Sciences sector (biotech, pharma and medical devices) and the Information Technology sector (semiconductors, photonics and advanced materials). NSV was founded in 2004 by Somu Subramaniam, Managing Partner, and Tom Lavin, Partner, and has invested approximately $500 million in early, mid- and late stage companies located in the US, Europe, India and China.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Grace Colon Senior Advisor
    Jean-Pierre Bizet Partner and Senior Advisor
    John Cecil Partner and Senior Advisor
    Lloyd Appel Chief Financial Officer
    Somu Subramaniam Managing Partner


    Portfolio companies include:

        web link

      Akarna Therapeutics
        web link

      Alexar Therapeutics
        web link

      Ario Pharma
        web link

        web link

        web link

      Boro Networks
        web link

        web link

        web link

        web link

      Ception Theraputics
        web link

        web link

      Dali Wireless
        web link

      Dezima Pharmaceuticals
        web link

      Directed Sensing
        web link

      Ferric Semiconductor

        web link

        web link

        web link

        web link

        web link

      Juventas Therapeutics
        web link

        web link

        web link

      Light Sciences Oncology
        web link

        web link

        web link

        web link

        web link

        web link

      Resolve Therapeutics
        web link

      RF Arrays
        web link

      Seahorse Bioscience
        web link

      Silicon Space Technology
        web link

        web link

      Svelte Medical Systems
        web link

        web link

        web link

      Tiger Text
        web link

      Trellis Bioscience
        web link


      VORAGO Technologies
        web link

      VUV Analytics
        web link

        web link


    Recent News: